Studies on anti SCF therapy in mice model of asthma demonstrated that inhibition of SCF led to reduction of eosinophil accumulation in the airways, attenuation of peribronchial remodeling and decrease in bronchial hyperreactivity [10-12]. Here, KITLG is linked to asthma.